Whether it's due to the birth of a child, a health problem or another personal issue, life often necessitates a break from work. But it can be tough to come back from an extended leave—especially in the STEM fields. Johnson & Johnson wants to help change that.
In the early 1980s, Cliff Morrison did what no other San Francisco General Hospital staff member had the guts to do: come up with a humane way to treat and care for AIDS patients. We sat down with him to learn more about the life-changing initiative—and how the legacy of Ward 5B lives on.
From a $10 million pledge to UNICEF in support of health workers to promising news about a preventive HIV vaccine regimen, the company’s new 2018 Health for Humanity Report details how Johnson & Johnson is dedicated to creating a better future for everyone, everywhere.
Siddhartha Mukherjee, M.D., made his name as an oncologist, researcher and Pulitzer Prize-winning writer. Now he's the scientific adviser of an immuno-oncology start-up that's tackling a rare form of leukemia. In an exclusive interview, he reveals his vision for the future of cancer treatments.
For Pride Month, Johnson & Johnson Executive Vice President Ashley McEvoy shares how the company stands behind its LGBTQ+ employees—and why a strong culture of diversity and inclusion is crucial to successfully finding solutions for the world's greatest healthcare problems.
A study of women, by women. We're talking about the Imbokodo trial, which is evaluating an investigational HIV vaccine in sub-Saharan Africa. As the study hits a key milestone, we sat down with South African physician and scientist Glenda Gray, who's at the helm of the groundbreaking trial.